CClinicalTrials.gg
CompletedNCT06228118Updated Jan 30, 2024

Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System

An observational study in Early Pregnancy, sponsored by Andon Health Co., Ltd. Completed at 1 site in China. Open to female participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-01-30.

Sponsored by Andon Health Co., Ltd · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
502
Ages
18 Years to 55 Years
Sex
Female
01

Study summary

This clinical trial consisted of lay user study and method comparison study. Method comparison study: evaluate the clinical performance by comparing the results of new device and FDA cleared device (the comparator) tested on the same sample by professionals.

Lay user study: evaluate the usability of by comparing the results of new device on the same sample tested by professionals and lay user, and by lay users complete the questionnaire.

02

Conditions studied

  • Early Pregnancy
03

In context

Lead sponsor

Andon Health Co., Ltd is the lead sponsor of 19 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A total of 502 subjects with ages from 18-55 years old were enrolled . Among the 502 total subjects, 369 subjects aged between 18 and 55 years old voluntarily participated in the Lay User Study.

Inclusion criteria

  1. Method comparison study exclusion criteria

    • Female;
    • 18-55 years of age;
    • Voluntary and sign informed consent form.
  2. Lay user study inclusion criteria

    • Female;
    • 18-55 years of age;
    • Voluntary and sign informed consent form;
    • Willingness to perform self-test of investigational device;
    • Have the ability to read English.

Exclusion criteria

Exclusion Criteria:

  1. Method comparison study exclusion criteria

    • Use of hCG-containing fertility medications (e.g., Pregnyl, Profasi, Novarel, Ovidrel);
    • Within 8 weeks of childbirth or abortion;
    • The investigator has reason to believe that it is inappropriate for subjects to participate in the study.
  2. Lay user study inclusion criteria

    • Use of hCG-containing fertility medications (e.g., Pregnyl, Profasi, Novarel, Ovidrel);
    • Within 8 weeks of childbirth or abortion;
    • The investigator has reason to believe that it is inappropriate for subjects to participate in the study;
    • Background in a medical or laboratory testing.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
502 participants (actual)
Patient registry
No

Groups and cohorts

  • Subjects enrolled in method comparison study only
  • Subjects enrolled in both the method comparison study and lay user study
06

What researchers measure

Primary outcomes

  1. Comparison results

    Compare the test results conducted by professionals using investigational device and the comparator, and the positive percent agreement (PPA=100%), negative percent agreement (NPA=100%) and overall percent agreement (OPA=100%) were calculated.

    Time frame: 30minute

Secondary outcomes

  1. Evaluate the usability and user comprehension of investigational device

    The accuracy rate of the critical task is 100%. The Overall Percent Agreement for investigational device is 100% when conducted by a lay user. The accuracy rate of the each questions in the Knowledge assessment is 100%, and 100% of the Ease of operation assessment chose normal, easy, or very easy.

    Time frame: 30minute

07

Study locations

1 site
  • First Teaching hospital of Tianjin University of Traditional Chinese Medicine
    Tianjin, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06228118
Lead sponsor
Andon Health Co., Ltd
Responsible party
Sponsor
First posted
Jan 29, 2024
Start date
Aug 4, 2023
Primary completion
Sep 2, 2023
Completion
Sep 2, 2023
Last update
Jan 30, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion